These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23383146)

  • 1. Targeted delivery of immunotoxin by antibody to ganglioside GD3: a novel drug delivery route for tumor cells.
    Torres Demichelis V; Vilcaes AA; Iglesias-Bartolomé R; Ruggiero FM; Daniotti JL
    PLoS One; 2013; 8(1):e55304. PubMed ID: 23383146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibody to GD3 ganglioside, R24, is rapidly endocytosed and recycled to the plasma membrane via the endocytic recycling compartment. Inhibitory effect of brefeldin A and monensin.
    Iglesias-Bartolomé R; Crespo PM; Gomez GA; Daniotti JL
    FEBS J; 2006 Apr; 273(8):1744-58. PubMed ID: 16623710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains.
    Kasahara K; Watanabe Y; Yamamoto T; Sanai Y
    J Biol Chem; 1997 Nov; 272(47):29947-53. PubMed ID: 9368072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody.
    Chapman PB; Gillies SD; Houghton AN; Reilly RM
    Cancer Immunol Immunother; 1994 Sep; 39(3):198-204. PubMed ID: 7522964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanoma cell lines deficient in GD3 ganglioside expression exhibit altered growth and tumorigenic characteristics.
    Nakano J; Raj BK; Asagami C; Lloyd KO
    J Invest Dermatol; 1996 Oct; 107(4):543-8. PubMed ID: 8823358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
    Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK
    J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside.
    Chapman PB; Yuasa H; Houghton AN
    J Immunol; 1990 Aug; 145(3):891-8. PubMed ID: 1695649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.
    Lund K; Bostad M; Skarpen E; Braunagel M; Kiprijanov S; Krauss S; Duncan A; Høgset A; Selbo PK
    MAbs; 2014; 6(4):1038-50. PubMed ID: 24525727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
    Helfand SC; Dickerson EB; Munson KL; Padilla ML
    Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.
    Ohta S; Honda A; Tokutake Y; Yoshida H; Hanai N
    Cancer Immunol Immunother; 1993; 36(4):260-6. PubMed ID: 8439988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro.
    Higgins SC; Fillmore HL; Ashkan K; Butt AM; Pilkington GJ
    Anticancer Res; 2015 Jan; 35(1):77-84. PubMed ID: 25550537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
    Welt S; Carswell EA; Vogel CW; Oettgen HF; Old LJ
    Clin Immunol Immunopathol; 1987 Nov; 45(2):214-29. PubMed ID: 3665201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
    Chapman PB; Lonberg M; Houghton AN
    Cancer Res; 1990 Mar; 50(5):1503-9. PubMed ID: 2105840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes modulated by expression of GD3 synthase in Chinese hamster ovary cells. Evidence that the Tis21 gene is involved in the induction of GD3 9-O-acetylation.
    Satake H; Chen HY; Varki A
    J Biol Chem; 2003 Mar; 278(10):7942-8. PubMed ID: 12493756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.
    Nasi ML; Meyers M; Livingston PO; Houghton AN; Chapman PB
    Melanoma Res; 1997 Aug; 7 Suppl 2():S155-62. PubMed ID: 9578432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma.
    Ramos AS; Parise CB; Travassos LR; Han SW; de Campos-Lima PO; de Moraes JZ
    Cancer Sci; 2011 Jan; 102(1):64-70. PubMed ID: 21070480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3.
    Tai T; Kawashima I; Furukawa K; Lloyd KO
    Arch Biochem Biophys; 1988 Jan; 260(1):51-5. PubMed ID: 2449128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis.
    Kanazawa J; Ohta S; Shitara K; Fujita F; Fujita M; Hanai N; Akinaga S; Okabe M
    Cancer Immunol Immunother; 2000 Jul; 49(4-5):253-8. PubMed ID: 10941908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24.
    Urmacher C; Cordon-Cardo C; Houghton AN
    Am J Dermatopathol; 1989 Dec; 11(6):577-81. PubMed ID: 2604027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
    Flavell DJ; Boehm DA; Noss A; Flavell SU
    Br J Cancer; 1997; 75(7):1035-43. PubMed ID: 9083340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.